Search

everythinglearnresearchcommunity

for

Search:↓

Different drugs for prostate-related urinary symptoms work but have various side effects, and treatment should be tailored to the individual.

Hair loss linked to metabolic issues and insulin resistance; early assessment may reduce future health risks.

New treatments for PCOS show promise, but no current medication treats all aspects of the condition.

Finasteride works best in 6 months and lasts 6 years.

Finasteride shows promise for female hair loss, but more research needed.

Hormone therapy for transgender females increases the risk of blood clots and requires careful dosing, monitoring, and lifelong management.

Dutasteride makes alcohol less sedating and may lead to less drinking in men.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

With careful management, people with congenital adrenal hyperplasia can have successful pregnancies and become parents.

The document concludes that menopause should be seen as a natural part of aging and managed with personalized care and informed choices.

Thymosin β4 helps improve skin healing and reduce scarring.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

17α-estradiol is a safe estrogen that might protect the brain and doesn't cause feminization, needing more research for treating brain diseases.

Using 17-hydroxyprogesterone levels to diagnose nonclassic congenital adrenal hyperplasia can result in many incorrect diagnoses.

Finasteride use linked to increased risk of sexual dysfunction, especially in younger people.

Early diagnosis and treatment are key to managing health risks in teens with PCOS.

Betacoronaviruses, like COVID-19, may cause hormone system dysfunction and affect disease susceptibility and severity.

Cyclodextrins improve how steroid drugs work and are used in marketed medications and environmental applications.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

Treatment can improve survival and symptoms in dogs with Cushing's disease, but outcomes are unpredictable.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Scientists have developed a new method to detect steroid abuse in athletes using cell-based tests, which could be the future of anti-doping methods.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

The androgen receptor is a promising target for breast cancer treatment, especially in triple-negative cases, but more research is needed for personalized therapies.

Topical cetirizine improves hair density and thickness in androgenetic alopecia, but more research is needed.

Delayed ejaculation is a complex issue caused by psychological, biological, and lifestyle factors, requiring a holistic treatment approach.